|Day Low/High||7.41 / 7.78|
|52 Wk Low/High||5.91 / 12.63|
Insiders have an edge in this complex sector, so it's worth checking them out.
Egalet, Portola Pharmaceuticals and Amicus Therapeutics hold promise for improvement.
Veterinary drug play Aratana Therapeutics is among the potential solid performers next year.
Small biotech tanked on weak earnings, but still seems promising.
As Brexit turmoil calms down, let's get back to small cap stocks.
Warren Buffett is satisfied with his IBM holdings, but is Jim Cramer satisfied with the stock? Not exactly.